Armata Pharmaceuticals Stock Market Value
| ARMP Stock | USD 2.25 0.15 7.14% |
| Symbol | Armata |
Armata Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Armata Pharmaceuticals. If investors know Armata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Armata Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.103 | Quarterly Revenue Growth 0.214 | Return On Assets (0.25) | Return On Equity (34.39) |
The market value of Armata Pharmaceuticals is measured differently than its book value, which is the value of Armata that is recorded on the company's balance sheet. Investors also form their own opinion of Armata Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Armata Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Armata Pharmaceuticals' market value can be influenced by many factors that don't directly affect Armata Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Armata Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Armata Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Armata Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Armata Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Armata Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Armata Pharmaceuticals.
| 12/04/2022 |
| 11/23/2024 |
If you would invest 0.00 in Armata Pharmaceuticals on December 4, 2022 and sell it all today you would earn a total of 0.00 from holding Armata Pharmaceuticals or generate 0.0% return on investment in Armata Pharmaceuticals over 720 days. Armata Pharmaceuticals is related to or competes with Eliem Therapeutics, HCW Biologics, RenovoRx, Tempest Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, and Seres Therapeutics. Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriopha... More
Armata Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Armata Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Armata Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.17 | |||
| Information Ratio | 0.0025 | |||
| Maximum Drawdown | 33.83 | |||
| Value At Risk | (7.05) | |||
| Potential Upside | 7.14 |
Armata Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Armata Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Armata Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Armata Pharmaceuticals historical prices to predict the future Armata Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0306 | |||
| Jensen Alpha | 0.0605 | |||
| Total Risk Alpha | (0.65) | |||
| Sortino Ratio | 0.0029 | |||
| Treynor Ratio | 0.2216 |
Armata Pharmaceuticals Backtested Returns
Armata Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0086, which signifies that the company had a -0.0086% return per unit of risk over the last 3 months. Armata Pharmaceuticals exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Armata Pharmaceuticals' Mean Deviation of 3.29, downside deviation of 4.17, and Risk Adjusted Performance of 0.0306 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.6, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Armata Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Armata Pharmaceuticals is expected to be smaller as well. At this point, Armata Pharmaceuticals has a negative expected return of -0.04%. Please make sure to confirm Armata Pharmaceuticals' downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Armata Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.01 |
Very weak reverse predictability
Armata Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between Armata Pharmaceuticals time series from 4th of December 2022 to 29th of November 2023 and 29th of November 2023 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Armata Pharmaceuticals price movement. The serial correlation of -0.01 indicates that just 1.0% of current Armata Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.01 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.32 |
Armata Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Armata Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Armata Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Armata Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Armata Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Armata Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Armata Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Armata Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Armata Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Armata Pharmaceuticals Lagged Returns
When evaluating Armata Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Armata Pharmaceuticals stock have on its future price. Armata Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Armata Pharmaceuticals autocorrelation shows the relationship between Armata Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Armata Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Armata Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Armata Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Armata Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Armata Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Armata Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Armata Pharmaceuticals to buy it.
The correlation of Armata Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Armata Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Armata Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Armata Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Armata Stock Analysis
When running Armata Pharmaceuticals' price analysis, check to measure Armata Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Armata Pharmaceuticals is operating at the current time. Most of Armata Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Armata Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Armata Pharmaceuticals' price. Additionally, you may evaluate how the addition of Armata Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.